Pharmafile Logo
Pharmafocus logo
Advanced Search

GSK

Showing 15 posts of 760 posts found.

EMA image

EMA publishes updated diabetes guidelines

July 2, 2012
Research and Development, Sales and Marketing Avandia, EMA, GSK, R&D, Takeda

The European Medicines Agency has published new guidance on what it wants to see from firms submitting new diabetes treatments. …

News
Witty image

Witty warns EU leaders over pricing

June 27, 2012
Sales and Marketing EFPIA, EU, GSK, Greece, R&D, Witty, pricing

Sir Andrew Witty has waded into the debate over Europe’s economic future with a plea for pharma innovation to be …

News
Novartis image

Pharma companies share $400m US biosecurity contract

June 26, 2012
Manufacturing and Production Emergent BioSolutions, GSK, Novartis, manufacturing

GlaxoSmithKline, Novartis and Emergent BioSolutions will share a $400 million contract from the US government to provide vaccine manufacturing capacity …

News

GSK partners with Cambridge University

June 18, 2012
Research and Development, Sales and Marketing ABPI, Cambridge, GSK, R&D

The University of Cambridge begins a new collaboration with GlaxoSmithKline today to advance drug discovery and the development of new …

News

PMCPA reprimands Chiesi for multiple breaches

June 18, 2012
Sales and Marketing COPD, Chiesi, GSK, PMCPA, code

Chiesi has been publicly reprimanded by the PMCPA part for promoting its asthma drug Fostair off-label. The embarrassing slapdown from …

News

GSK pays £146 million for eczema drug

June 13, 2012
Sales and Marketing Basilea, GSK, Stiefel, Toctino

GlaxoSmithKline has paid £146 million for Basilea Pharmaceutica’s dermatology drug Toctino. Toctino (alitretinoin) is approved for the treatment of adults …

News
Lilly oncology image

Lilly app aims to boost trial recruitment

June 8, 2012
Medical Communications GSK, clinical trials, lilly, oncology

Lilly has launched a new searchable clinical trial mobile app for oncologists. The app is available for the iPad and …

News
human genome sciences

HGS shareholder challenges ‘poison pill’

May 31, 2012
Sales and Marketing Benlysta, GSK, HGS, hostile bid

The saga of GlaxoSmithKline’s attempt to take over Human Genome Sciences (HGS) has taken another turn with legal action by …

News

Photo story: GSK’s 2012 legacy

May 30, 2012
Research and Development Andrew Witty, GSK, Olympics 2012

Tuesday May 29, 2012: GlaxoSmithKline chief executive, Sir Andrew Witty makes a speech at a conference at the company’s headquarters …

Feature

GSK starts combination trial for melanoma

May 30, 2012
Research and Development, Sales and Marketing GSK, R&D, Roche, Zelboraf, melanoma

GlaxoSmithKline has begun a combination trial for two of its investigational skin cancer drugs.  The firm will combine dabrafenib, its …

News
Richard Bergstrom

Public-private alliance to discover new antibiotics

May 25, 2012
AstraZeneca, EFPIA, GSK, Janssen, Sanofi, antibiotic, bacterial infection

 A Europe-wide public-private partnership is to put €224m (£180m) into finding new antibiotics for all manner of bacterial infections such …

News

Ovarian cancer charity wins GSK/King’s Fund award

May 21, 2012
Medical Communications, Sales and Marketing GSK, awards, charity, king's fund, ovarian cancer

A charity which aims to increase the chances of survival for patients with a poorly-treated form of cancer is to …

News

GSK buys more of Theravance

May 18, 2012
Research and Development, Sales and Marketing COPD, Cellzome, GSK, Relovair, Theravance

GlaxoSmithKline now owns more than a quarter of biopharma company Theravance after shelling out nearly $213 million to buy ten …

News
GSK picture

GlaxoSmithKline to acquire Cellzome for £61 million

May 15, 2012
Research and Development, Sales and Marketing Cellzome, Domantis, GSK, R&D

GlaxoSmithKline will expand its platform technology capability with the acquisition of a chemical proteomics company.  GSK will acquire those shares …

News

GSK raises bid for Human Genome Services

May 9, 2012
Research and Development, Sales and Marketing GSK, Human Genome Services, bid, takeover

The latest round in GlaxoSmithKline’s attempt to take over Human Genome Services has begun with GSK appealing directly to the …

News
The Gateway to Local Adoption Series

Latest content

STADA and Bio-Thera’s Gotenfia receives positive CHMP opinion for autoimmune diseases

December 18, 2025

Norgine enters exclusive licensing agreement with Vir Biotechnology

December 18, 2025

Incyclix appoints Kimberly Blackwell to Board of Directors

December 17, 2025

Hansa Biopharma appoints Max Sakajja as Vice President, General Manager Europe and International

December 17, 2025

GSK’s Exdensur receives MHRA approval for asthma and rhinosinusitis

December 16, 2025